Sunday, January 11, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

CurtissWright Corporations Impending Earnings Report and Investor Expectations

Elaine Mendonca by Elaine Mendonca
February 13, 2024
in Breaking News
0
Biomedicine plant based
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

Curtiss-Wright Corporation is set to unveil its latest quarterly earnings report on February 14, 2024. With this impending announcement, here are some crucial points for investors to consider:

Earnings Per Share (EPS) Estimate: Analysts have projected an EPS of $2.92 for Curtiss-Wright in the current quarter.

Investor Expectations: Investors who hold a bullish outlook on Curtiss-Wright will be eagerly anticipating the company to surpass the EPS estimate and provide a positive outlook for future growth.

The Significance of Guidance: It’s important for new investors to recognize that a company’s guidance for future performance can have a substantial impact on stock price movements, often outweighing whether the company beats or misses earnings estimates.

Previous Earnings Performance:

Last Quarter: Curtiss-Wright exceeded the EPS estimate by $0.16 in the previous quarter, resulting in a 1.94% increase in the stock price the following day.

Historical Earnings and Price Changes:

Quarter EPS Estimate EPS Actual Price Change %
Q3 2023 2.38 2.54 1.94%
Q2 2023 1.96 2.15 4.76%
Q1 2023 1.39 1.53 -4.6%
Q4 2022 2.91 2.92 3.64%

Stock Performance:

Current Trading Price: As of February 12, Curtiss-Wright’s shares were trading at $228.64.

52-Week Performance: Over the past year, the stock has witnessed a 31.36% increase, indicating a positive trend for long-term shareholders.

Investors interested in keeping track of Curtiss-Wright’s earnings releases can access the information on the company’s earnings calendar through financial news and data websites.

Strong Performance of CW Stock on February 13, 2024 Indicates Positive Market Sentiment and Growth Potential

CW stock exhibited a strong performance on February 13, 2024. The price of CW shares increased by $0.09 since the market last closed, representing a rise of 0.04%. CW stock opened at $226.70, which was $1.94 lower than its previous close, but quickly recovered and showed an overall increase in price. Trading near the top of its 52-week range and being above its 200-day simple moving average indicate positive market sentiment and potential for further growth.

CW Stock Performance on February 13, 2024: Revenue Holds Steady, Net Income and EPS Show Growth

CW Stock Performance on February 13, 2024: Revenue Holds Steady, Net Income and EPS Show Growth

CW stock displayed a stable performance on February 13, 2024, with its total revenue remaining flat compared to the previous year and the previous quarter. Despite the lack of revenue growth, the company achieved positive results in terms of net income and earnings per share (EPS).

CW reported a total revenue of $2.56 billion over the past year, which remained unchanged from the previous year’s figure. Similarly, the company’s total revenue for the third quarter of 2023 stood at $724.33 million, showing no growth compared to the previous quarter.

However, CW showcased growth in its net income. Over the past year, the company recorded a net income of $294.35 million, marking a 10.18% increase from the previous year. In the third quarter of 2023, CW’s net income reached $96.78 million, reflecting an even higher growth rate of 19.48% compared to the previous quarter.

The positive trend continued with CW’s earnings per share (EPS). The company’s EPS for the past year amounted to $7.62, representing a 15.74% increase from the previous year. In the third quarter of 2023, CW’s EPS stood at $2.51, exhibiting a growth rate of 19.47% compared to the previous quarter.

These figures suggest that CW improved its profitability despite stagnant total revenue. The growth in net income and EPS may be attributed to effective cost management strategies or increased demand for the company’s products or services.

Investors may find CW’s performance on February 13, 2024, encouraging, as the company delivered positive results in terms of net income and EPS growth. However, it is essential to consider other factors, such as market conditions and industry trends, before making any investment decisions.

Overall, CW’s stock performance on February 13, 2024, demonstrated stability in revenue but growth in net income and EPS. Investors should closely monitor future financial reports to gauge the company’s ability to sustain and further improve its profitability.

Tags: CW
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Tech-banking-finance

Anticipation Builds for NorthWesterns Quarterly Earnings Report and Future Outlook

Finances

Sonoco Products Earnings Report and Stock Performance Analysis

Cups of coffee

MicroCloud Hologram Inc HOLO Trading Resumes with Impressive 278 Surge

Recommended

Transportation Stock Bull Market

JR Kyushu Implements AIPowered AMD Kria K26 SOM for Enhanced Track Inspection Efficiency and Safety

2 years ago
TMUS stock news

Wedbush Analyst Maintains Outperform Rating and Raises Price Target for Global Payments

2 years ago
JD.com Stock

JD.com Shares Surge on Robust Performance and Strategic Moves

3 months ago
Mobile-handsets

Palantir Technologies Reveals Revenue Projections for Q1 2024

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Procter & Gamble Shares Approach a Critical Juncture

Vital Farms Shares Face Headwinds Amid Forecast Revisions and Insider Activity

Palantir Shares: A Wall Street Divide and a Bold New Price Target

Nvidia Accelerates AI Dominance with Early Chip Launch and Strategic Expansions

Netflix Shares Under Pressure Amid High-Stakes Acquisition Battle

Marvell Technology Shares Face Conflicting Market Cues

Trending

Viking Therapeutics Stock
Analysis

Viking Therapeutics: A Tale of Clinical Progress and Insider Selling

by Felix Baarz
January 11, 2026
0

The shares of Viking Therapeutics, a biotechnology firm, are presenting investors with a conflicting narrative this week....

Astera Labs Stock

Astera Labs Shares Face Selling Pressure Amid Strong Fundamentals

January 11, 2026
Realty Income Stock

Institutional Investors Increase Stakes in Realty Income Amid Strategic Refinancing

January 11, 2026
Procter & Gamble Stock

Procter & Gamble Shares Approach a Critical Juncture

January 11, 2026
Vital Farms Stock

Vital Farms Shares Face Headwinds Amid Forecast Revisions and Insider Activity

January 11, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Viking Therapeutics: A Tale of Clinical Progress and Insider Selling
  • Astera Labs Shares Face Selling Pressure Amid Strong Fundamentals
  • Institutional Investors Increase Stakes in Realty Income Amid Strategic Refinancing

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com